I assume it is really Genentech driving this They say that it is often conducted in close collaboration between Genentech Research and Early Development with the Roche Diagnostics division http://www.rocheusa.com/fmfiles/re7180004/2012_Oncology_Pipeline_Brochure_Int.pdf Perhaps it is rare but this is where they should all be moving to, imo.